ARA-290 is a synthetic peptide derived from the erythropoietin (EPO) molecule. It was developed to retain the anti-inflammatory and neuroprotective properties of EPO without the erythropoietic (red blood cell production) effects. ARA-290 is primarily known for its potential to alleviate neuropathic pain and improve tissue repair, making it a promising therapeutic candidate for conditions like small fiber neuropathy (SFN) and autoimmune diseases.
ARA-290 was developed through research focused on creating a peptide that mimicked the neuroprotective and tissue-repairing properties of erythropoietin without stimulating red blood cell production. Researchers discovered that the small fragment of EPO, ARA-290, could activate the innate repair receptor (IRR), leading to its use in treating inflammatory and neuropathic conditions. Since its discovery, it has gained attention for its potential to relieve pain and improve the quality of life for individuals suffering from neuropathic diseases.
Neuropathic Pain Relief:
Small Fiber Neuropathy (SFN):
Tissue Repair and Regeneration:
Anti-Inflammatory Effects:
Autoimmune Disease Support:
SKU: MAF-ARA10mg-SV-KIT
WhatsApp us